Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Susan E. Atkins currently holds 17,000 shares of BioXcel Therapeutics, Inc. (BTAI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Susan E. Atkins has been a net neutral trader of BTAI stock. They have purchased $0 and sold $0 worth of shares.
Susan E. Atkins's most recent insider trade was on Aug 12, 2026, when they sold 17,000 shares at $0.00 per share.
Susan E. Atkins serves as Executive at BioXcel Therapeutics, Inc. (BTAI). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Susan E. Atkins holds the position of Executive at BioXcel Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Susan E. Atkins has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Susan E. Atkins was on Aug 12, 2026, when they purchased $0 worth of BTAI shares. This transaction involved 17,000 shares at N/A per share.
Susan E. Atkins currently owns 17,000 shares of BioXcel Therapeutics, Inc. (BTAI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Susan E. Atkins's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Susan E. Atkins has 1 Form 4 filings on record as an insider at BioXcel Therapeutics, Inc..
Set alerts for Susan E. Atkins and 40,000+ other insiders.